Hannah Beird

Medicine & Life Sciences

1. Polypyrimidine Tract-Binding Protein 100%
2. Neoplasms 96%
3. Desmoplastic Small Round Cell Tumor 93%
4. Osteosarcoma 85%
5. Small Cell Sarcoma 73%
6. Glioma 67%
7. Genes 62%
8. Glioblastoma 60%
9. Acute Myeloid Leukemia 59%
10. Mutation 54%
11. Liposarcoma 52%
12. Androgen Receptors 43%
13. Familial Acute Myeloid Leukemia with Mutated Cebpa 42%
14. Cell Line 40%
15. Core Binding Factor beta Subunit 37%
16. Alternative Splicing 37%
17. Cold Temperature 36%
18. RNA Splicing Factors 36%
19. Phosphoglycerate Dehydrogenase 35%
20. Sarcoma 34%
21. High-Throughput Nucleotide Sequencing 33%
22. Genome 33%
23. Granulosa cell tumor of the ovary 32%
24. Myxoid Liposarcoma 31%
25. Ganglioglioma 30%
26. Exons 29%
27. T-Lymphocytes 29%
28. Granulosa Cell Tumor 29%
29. T-Lymphoid Precursor Cells 29%
30. B-Cell Leukemia 28%
31. Mucormycosis 28%
32. Therapeutics 28%
33. Protein Phosphatase 1 27%
34. T-Cell Antigen Receptor 27%
35. Synovial Sarcoma 27%
36. Protein Domains 27%
37. Tumor Cell Line 27%
38. Neurofibrosarcoma 27%
39. Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 26%
40. Hematologic Neoplasms 25%
41. Whole Genome Sequencing 25%
42. Mechanistic Target of Rapamycin Complex 1 25%
43. Carcinogenesis 25%
44. Mycobiome 24%
45. Cytokine Receptors 24%
46. Rhabdomyosarcoma 24%
47. Radiation Effects 24%
48. Gene Amplification 23%
49. Genetic Predisposition to Disease 23%
50. RNA Precursors 23%